Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Kinross Gold | 5.17% | $2.42M | $30.87B | 140.28% | 72 Outperform | |
| Sony | 4.18% | $1.96M | ¥26.47T | 59.23% | 74 Outperform | |
| Novartis AG | 4.13% | $1.94M | CHF194.55B | 9.68% | 80 Outperform | |
| Sandoz Group Ltd | 4.04% | $1.89M | CHF23.72B | 47.37% | 59 Neutral | |
| BAE Systems | 3.93% | $1.85M | £50.36B | 35.95% | 66 Neutral | |
| Nutrien | 3.88% | $1.82M | C$38.03B | 17.47% | 68 Neutral | |
| Rio Tinto Limited | 3.64% | $1.71M | AU$182.53B | 15.33% | 78 Outperform | |
| AstraZeneca | 3.15% | $1.48M | £210.77B | 35.66% | 76 Outperform | |
| Rexel SA | 3.08% | $1.45M | €9.16B | 25.62% | 65 Neutral | |
| Prosus | 3.03% | $1.42M | €126.70B | 64.24% | 77 Outperform |